Reuters logo
2 个月前
BRIEF-Immune Pharma announces initiation of enrollment in clinical trial with Ceplene
2017年6月20日 / 下午1点20分 / 2 个月前

BRIEF-Immune Pharma announces initiation of enrollment in clinical trial with Ceplene

June 20 (Reuters) - Immune Pharmaceuticals Inc

* Immune pharmaceuticals announces initiation of enrollment in clinical trial with ceplene®/ low-dose il-2 in chronic myelomonocytic leukemia (cmml)

* Immune pharmaceuticals - patient enrollment in clinical trial with ceplene/ low-dose il-2 in cmml is expected to begin in coming weeks Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below